01548

金斯瑞生物科技

13.680

-0.280-2.01%
Closed16:08 05/29 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE13.960/12.140
TODAY RANGE13.960-15.600
VOL39.11M
MARKET CAP31.42B
52 WEEK RANGE10.360-19.400
AVG VOL (3M)11.11M
% TURNOVER1.79%
TURNOVER569.78M
P/E (TTM)-7.578
% RANGE13.51%
EPS(TTM)-1.895
P/E(FORWARD)53.107
P/B1.020
BVPS14.081
DIVIDEND--
P/S4.208
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP31.42B
SHARES OUTSTANDING2.19B
NEXT EARNINGS08/14-08/18
FREE FLOAT2.19B
LOT SIZE2000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

金斯瑞生物科技

01548

-2.01%
13.680

昊海生物科技

06826

+0.05%
18.230

藥明康德

02359

+3.82%
130.300

H

Hangzhou Tigermed Consulting

03347

+2.72%
30.940

昭衍新藥

06127

+1.35%
17.990

康龍化成

03759

+0.75%
17.520

01035

--

方達控股

01521

-2.78%
0.700

C

China Regenerative Medicine International

08572

0.00%
0.010

中國醫療集團

08225

0.00%
0.124

00233

--

維亞生物

01873

+0.80%
1.260

邁博藥業-B

02181

-1.25%
0.395

中國再生醫學

08158

+8.11%
0.400

東曜藥業-B

01875

+0.73%
4.140

華領醫藥-B

02552

-3.31%
2.630

微創腦科學

02172

+2.68%
9.200

康寧傑瑞製藥-B

09966

-8.90%
8.290

中國抗體-B

03681

+3.33%
1.240

樂普生物

02157

+4.41%
4.260

加科思-B

01167

+4.70%
4.900

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.